Ira Jacobson
Director of Clinical Research, Hepatology Program · NYU Grossman School of Medicine
Credentials: · · · ·
History
PresentHepatology Program · NYU Grossman School of Medicine
- Present
Clinical Research Hepatology Program · NYU Grossman School of Medicine
- 1982–1984
Research
Boceprevir for untreated chronic HCV genotype 1 infection
New England Journal of Medicine · 2011 · 2,030 citations
Telaprevir for previously untreated chronic hepatitis C virus infection
New England Journal of Medicine · 2011 · First of 24 authors · Corresponding · 1,955 citations
New England Journal of Medicine · 1989 · 1,618 citations
37 papers
- MS
35 papers
30 papers
- JM
27 papers
24 papers
- ZY
22 papers
21 papers
18 papers
Grants
- 2006–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $4.9K · Weill Medical Coll of Cornell Univ
Clinical trials
- 2008–2010
Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Principal investigator · Completed · Phase 2
Romark Laboratories L.C.
- 2007–2010
Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
Principal investigator · Completed · Phase 2
Romark Laboratories L.C.
Principal investigator · Completed · Phase 3
Weill Medical College of Cornell University
- 2025–2032
Site PI · Recruiting · Phase 3
Eli Lilly and Company